Overview
Laia Sadeghi practices practicing medicine in Stockholm, Sweden.
Ms. Sadeghi is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Mantle Cell Lymphoma (MCL) and Non-Hodgkin Lymphoma.
She is actively involved in clinical research, co-authoring 8 peer reviewed articles.
Gender
Locations
Stockholm, AB 17177, Sweden
Huddinge, AB, Sweden
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Laia Sadeghi
Is Laia Sadeghi a top-rated expert for Mantle Cell Lymphoma (MCL)?
MediFind is an objective health platform that identifies experts based on real-world data. Laia Sadeghi is classified as an Advanced expert for Mantle Cell Lymphoma (MCL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Laia Sadeghi participate in research or clinical trials?
Yes. Laia Sadeghi has published 8 articles and abstracts on conditions like Mantle Cell Lymphoma (MCL). You can view a list of Laia Sadeghi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Mantle Cell Lymphoma (MCL)Ms. Sadeghi isAdvanced. Learn about Mantle Cell Lymphoma (MCL).
- Experienced
- Non-Hodgkin LymphomaMs. Sadeghi isExperienced. Learn about Non-Hodgkin Lymphoma.